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Lectins from dietary plants have been shown to enhance drug absorption in the gastroin-
testinal tract of rats, be transported trans-synaptically as shown by tracing of axonal and 
dendritic paths, and enhance gene delivery. Other carbohydrate-binding protein toxins 
are known to traverse the gut intact in dogs. Post-feeding rhodamine- or TRITC-tagged 
dietary lectins, the lectins were tracked from gut to dopaminergic neurons (DAergic-N) 
in transgenic Caenorhabditis elegans (C. elegans) [egIs1(Pdat-1:GFP)] where the mutant 
has the green fluorescent protein (GFP) gene fused to a dopamine transport protein 
gene labeling DAergic-N. The lectins were supplemented along with the food organism 
Escherichia coli (OP50). Among nine tested rhodamine/TRITC-tagged lectins, four, 
including Phaseolus vulgaris erythroagglutinin (PHA-E), Bandeiraea simplicifolia (BS-I), 
Dolichos biflorus agglutinin (DBA), and Arachis hypogaea agglutinin (PNA), appeared 
to be transported from gut to the GFP-DAergic-N. Griffonia Simplicifolia and PHA-E, 
reduced the number of GFP-DAergic-N, suggesting a toxic activity. PHA-E, BS-I, Pisum 
sativum (PSA), and Triticum vulgaris agglutinin (Succinylated) reduced fluorescent 
intensity of GFP-DAergic-N. PHA-E, PSA, Concanavalin A, and Triticum vulgaris agglu-
tinin decreased the size of GFP-DAergic-N, while BS-I increased neuron size. These 
observations suggest that dietary plant lectins are transported to and affect DAergic-N 
in C. elegans, which support Braak and Hawkes’ hypothesis, suggesting one alternate 
potential dietary etiology of Parkinson’s disease (PD). A recent Danish study showed that 
vagotomy resulted in 40% lower incidence of PD over 20 years. Differences in inherited 
sugar structures of gut and neuronal cell surfaces may make some individuals more 
susceptible in this conceptual disease etiology model.
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inTrODUcTiOn
Could dietary plant proteins, such as lectins, traverse the gut 
intact, with vesicular transfer to neurons and be transported 
intact along axons to affect dopaminergic neurons (DAergic-N) 
as one etiology of Parkinson’s disease (PD)? A recent Danish 
study showed that patients who had vagal nerves removed 
20 years ago had a 40% lower incidence of PD (1). Some reports 
claim that vegetarians have higher rates of PD (2, 3). This study 
uses C. elegans as a model to investigate dietary lectin transport 
to DAergic-N.
Plant lectins were discovered over a century ago (4). Toxicity 
of some lectins was first recognized, independently, by Bruylants 
and Vennemann (5); Warden and Waddell (6) [described by 
Oppenheimer (7) and Dixson (8)]. Lectins’ hemagglutination 
properties were found by Stillmark (9), and a general recognition 
of antigenicity by lectins was revealed by Paul Ehrlich in 1890 
(10) who won a Nobel Prize in Physiology or Medicine 1908 
“in recognition of their work on immunity”1. Thereafter, lectins’ 
“immune recognition” was used for immunological research [see 
Textbook of Military Medicine (11)]. In 1919, Sumner crystal-
lized (Canavalia ensiformis, Concanavalin A) (12). A half century 
later, investigators began to determine ABO-blood subtypes 
due to their sugar-binding properties, and the name “lectins” 
was formally coined (13, 14). Recent studies report that lectins 
play important roles in plant defense (15) and legume–rhizobial 
interactions (16).
Plants contain glycoprotein-lectins (“non-immune sugar-
binding proteins”) in seeds, fruits, and nuts (2), and recognize 
and reversibly bind specific carbohydrates (17). They are involved 
in plant defense (15) and legume–rhizobia (16). Upon consump-
tion by animals, they resist gut proteolytic enzymes, maintaining 
function under adverse gastrointestinal (GI) conditions (18, 
19). They can penetrate the GI tract wall by endocytosis (20), 
probably by first binding a carbohydrate lectin receptor (21). 
Astonishingly, intact lectins can transfer trans-synaptically in an 
antegrade and/or retrograde fashion along nerve fibers (17, 22). 
Their medical importance is increasingly being recognized by 
being conjugated with drugs for better drug absorption from the 
GI tract (21, 23–25). Particularly relevant to the current studies, 
lectins have been utilized extensively for neuronal tracing studies 
[see review (22, 26)]. Ricin (Ricinus communis) as an extremely 
cytotoxic lectin has been studied extensively for its function in 
retrograde transport, via a galactose-binding β-chain-mediated 
endocytosis, following translocation of the enzymatically active 
and toxic A-chain, from the endosomes to the Golgi apparatus 
(27, 28). This property has been utilized for treatment of malig-
nancies at low doses (29, 30). Lectins have also been conjugated 
with DNA for enhanced nervous system gene delivery (31). Most 
dietary plant lectins resist gut proteolytic enzymes and maintain 
function under usually adverse conditions for proteins (18, 19). 
Non-toxic lectins, such as tomato lectin and wheat germ aggluti-
nin, are suggested to show growth factor activity in the GI tract 
(18). Bacteria or parasitic protozoa, through their own lectins, 
1 http://www.nobelprize.org/nobel_prizes/medicine/laureates/1908/
attach to carbohydrate receptors on epithelial cells to colonize 
the GI and genito-urinary tracts. Some lectins are synergistically 
toxic both locally and systemically to experimental animals (18). 
Kidney bean lectin (PHA), for example, damages intestinal epi-
thelial cells, causes bacterial overgrowth, and induces nutritional 
disorders, effects which are preventable by inhibition with the 
specific sugars that have competitive binding capacities to lectins 
by sharing similar terminal structures (18, 32). Likewise, dietary 
saccharides or glycoconjugates, such as probiotic agents and 
milk oligosaccharides, may act as receptor analogs or decoys to 
selectively and competitively reduce lectin binding (18, 33, 34). 
Soybean lectin has shown potential anticarcinogenic effects (35).
Complex environmental factors play important roles for neu-
rodevelopmental and neurodegenerative disorders, including PD 
(36, 37). Controversial reports suggest that a higher prevalence 
of PD occurs in vegetarians compared to omnivores (3, 38). In 
equine Parkinsonism, consuming yellow star thistles (Centaurea 
solstitialis) or Russian knapweed (Acroptilon repens) causes liquid 
necrosis in the substantia nigra pars reticulata and the globus 
pallidus by destroying DAergic-N, developing nigropallidal 
encephalomalacia (NPE), and creating histopathological features 
that resemble human idiopathic PD (39). These observations 
suggest transport of toxic substances from the horse gut to brain 
neurons. To date, however, in humans, epidemiology has not 
proven dietary lectins to have a significant impact on neuronal 
degenerative diseases. Signature pathologies of PD, e.g., Lewey’s 
bodies and aggregated alpha-synuclein (α-SYN) occur in neurons 
of the enteric nervous system of the GI wall, in addition to the 
neurons of the central nervous system (CNS) (40). α-SYN also 
aggregates in microglia and further leads to PD though the 
detailed mechanism remains unclear (41, 42), while astrocytes 
convert neurotoxin MPTP to its active metabolite MPP+ (43). The 
findings reported here support Braak and Hawkes’ hypothesis 
that the GI tract may be a potential site of neuronal invasion by 
an “unknown etiologic agent,” potentially responsible for causing 
some percentage of PD (40, 44–47). It is suggested herein that one 
possible etiologic agent could be dietary lectins.
Caenorhabditis elegans has a high conservation (>65%) 
of human disease-associated genes (48, 49). A total of eight 
DAergic-N in the hermaphrodite C. elegans (50–52) respond 
to signals from environmental mechano-sensory stimuli, e.g., 
exhausted food supply, which have offered molecular, genetic, 
and behavioral tools to aid human disease studies (53–57). C. 
elegans modulates locomotion behavior by using dopamine 
and serotonin to mediate motor circuits in chemical synapses, 
gap junctions, and neuromuscular junctions (58–60). Intestinal 
muscle cells are innervated by pharyngeal motor neurons 
and bioaminergic neurons via the preanal ganglia. Structures, 
sensory-motor synapses, gap junction contacts, and activities all 
resemble those in the mammalian GI tract (61, 62).
The features of the green fluorescent protein (GFP)-dopamine 
transporter (DAT) fusion protein C. elegans [egIs1(Pdat-1:GFP)] 
were evaluated by the numbers, fluorescent intensity, and sizes 
of GFP-DAergic-N in this study. Meanwhile, TRITC-labeled 
lectins were also followed post-feeding to establish the ability 
of lectins to bind or penetrate the GI wall or nerve cells. The 
question was whether dietary plant lectins can be transported 
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to, and impair or alter apparently DAergic-N. Differences in 
inherited sugar structures of gut and neuronal cell surface may 
make some individuals more susceptible in this conceptual 
disease model.
MaTerials anD MeThODs
Caenorhabditis elegans (egIs1[Pdat-1:GFP]) that express GFP in 
the eight DAergic-N (63, 64) and the standard food Escherichia 
coli (E. coli) were obtained from C. elegans Genetics Center (CGC, 
MN). The C. elegans model does not require regulation of the 
Institutional Animal Care and Use Committee (IACUC).
C. elegans culture
Caenorhabditis elegans were egg-synchronized, fed ad  libitum 
with LB broth (200  μl/agar plate or 250  μl/well) containing 
OP50 5 × 108–5 × 1011 cfu/ml (65), grown in nematode growth 
media (NGM) agar plates (∅35 mm, 3 ml) and transported to 
new plates every other day (n = 20). Or, seeded in 96-well plate 
(n  =  10–15/well) grown in liquid culture supplemented with 
fluorodeoxyuridine (FUDR, 0.6 mM/30 μl) (66). The plate was 
tape sealed, bagged, and covered with aluminum foil, and kept in 
a 20°C low temperature incubator (Revco Tech., Nashville, NC, 
USA) throughout the experiments.
All treatments were applied at day 3 after hatching. Four 
dose–responses of nine lectins were obtained for each culture 
condition in a dark room. Control animals were fed with OP50. 
Experimental groups were fed TRITC/rhodamine-conjugated 
lectins. The lectins were incorporated into feeding medium with 
OP50. Two hundred microliter treatments were added into each 
fresh agar dish prior to the transfer or 5 μl/well/week to liquid 
culture. Each group of nematodes was collected and fixed by 
15–20 days for the agar dish culture as previously described (67), 
after the first week for the liquid culture.
culture of Escherichia coli (OP50)
OP50 (10 μl) and streptomycin (10 μl/ml) were mixed with LB 
Broth (100 ml, see below) for 16 h at 37°C in an incubator and 
stored at 4°C for up to 3 months.
select lectins
Commercially available plant lectins conjugated to TRITC or 
rhodamine were from EY labs (San Mateo, CA, USA), Vector 
Labs (Burlingame, CA, USA), or Sigma-Aldrich (St. Louis, MO, 
USA). Doses of lectins (millimolar) used were comparable to 
those used in published work in neuronal tracing (17, 22, 26).
average Probability of survival assay
All average probability of survival (APS) assays was conducted in 
liquid culture (96-well plate). The animals were synchronized and 
seeded into each well of a plate (n = 10–15) and OP50 was added 
to each well. Thirty microliters (0.6 mM) of FUDR were added to 
each well to sterilize the animals. Four different treatments of lec-
tins (50 μl/treatment, n = 6 row) were added. The plate was then 
covered with aluminum foil. The whole procedure was performed 
in a dark room to prevent bleaching of fluorophores. The survival 
animals were counted every other day until all were dead.
Fluorescent Microscopy
The GFP-DAergic-N were identified by FTIC filter (480Ex/520Em) 
and the number of GFP-DAergic-N counted. Fluorescent intensity 
of GFP-DAergic-N and their average sizes (square micrometer) 
were determined by NIS-Elements Advanced Research (version 
3.22.11) and compared among the following groups: control and 
lectins. Fluorescent intensity of rhodamine-lectins was deter-
mined by a TRITC filter (580Ex/620Em) to assess co-localization. 
The magnitude of the effect(s) of the lectin on the DAergic-N, the 
number, fluorescent intensity (arbitrary unit), and sizes (square 
micrometer) of GFP-DAergic-N were determined and compared 
among each group. Co-localization was initially identified with 
an inverted microscopy (Nikon, Eclipse Ti–S, Japan) and then 
confirmed at a Z-axle with laser scanning microscopy (Leica, TCS 
SP5, Germany).
solutions and chemicals
Standard NGM agar plates (g): NaCl 3.0 g, Bacto-agar (Becton, 
MD, USA) 20  g, Bacto-peptone 2.5  g (Becton, MN, USA), 
Cholesterol solution 0.1% (0.005/ml 95% ethanol), and dH2O 
975ml were mixed. Additions to the autoclaved solution (M): 
CaCl2 1.0 1 ml, MgSO4 1.0 1 ml, KPO4 pH6 1.0 25 ml. LB Broth: 
25.0 g, dH2O 1 l (autoclave). S-basal solution (M): NaCl 0.1, KPO4 
pH6 0.05, Cholesterol 0.1%, was autoclaved. PBS (millimolar): 
115 NaCl, 75 Na2HPO4•7H2O, and 7.5 KH2PO4, pH 7.4.
statistical analyses
Analyses were carried out using SAS/STAT® software, Version 9.4 
of the SAS System for Windows (Cary, NC, USA). All results were 
expressed as mean  ±  SEM. Survival curves were displayed by 
binomial probabilities obtained from logistic regression models 
as surrogates for survival probabilities and mean lifespan was 
estimated via Kaplan–Meier (log rank). ANOVA models were 
used to analyze fluorescence intensity data. For each group, 20 
animals were analyzed for agar culture and 10–15 animals were 
analyzed for liquid culture. Statistical significance was defined as 
P < 0.05.
resUlTs
Diets supplemented with varying concentrations of rhodamine-
labeled lectins Phaseolus vulgaris erythroagglutinin (PHA-E), 
Bandeiraea simplicifolia (BS-I), or Dolichos biflorus agglutinin 
(DBA) in agar dish, or TRITC-conjugated Arachis hypogaea 
agglutinin (PNA) in liquid culture were fed to C. elegans, and 
subsequently detected by fluorescence microscopy associated 
with GFP-DAergic-N (Table  1). The only explanation for this 
observation is that rhodamine- or TRITC-labeled lectins traveled 
in some manner from the gut to the neurons. We observed that 
some lectins had the following effects: (a) reducing the number 
of DAergic-N, (b) decreasing fluorescent intensity of GFP-
expressing neurons (less GFP-DAT), or (c) altering neuron size. 
GSL-I, Con A, Pisum sativum (PSA), WGA, or S-WGA were not 
detected as transported to neurons, but nevertheless, some had 
significant effects on the neuron measurements, possibly indicat-
ing that undetectable amounts of these lectins caused the effects, 
TaBle 1 | lectins detected in the neurons by co-localization.
lectins Dose (mM) gFP # gFP intensity gFP size







6.0 × 10−4 P > 0.05 P < 0.01 P > 0.05
2.0 × 10−3 P < 0.01 P < 0.01 P < 0.01
Bandeiraea simplicifolia (BS-I)-TRITC 5.3 × 10−4 ↓ P > 0.05 ↓ P < 0.01 ↑ P < 0.01
1.8 × 10−3 P > 0.05 P < 0.01 P < 0.01
Dolichos biflorus (DBA)-rhodamine 1.0 × 10−3 ↔ P > 0.05 ↔ P > 0.05 ↔ P > 0.05
3.3 × 10−3







5.4 × 10−5 P > 0.05 P > 0.05 P > 0.05
1.8 × 10−4 P < 0.01 P < 0.01 P < 0.01
↓ Decreasing trend.
↑ Increasing trend.
↔ No significant alternation.
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or that some unexplained secondary effect of the lectins caused 
pathological effects.
lectins co-localized with the  
gFP-Daergic neurons
Phaseolus vulgaris erythroagglutinin-rhodamine co-localized 
with GFP-DAergic-N within 2  weeks after feeding (Figure  1). 
The number of GFP-DAergic-N was reduced in a dose-dependent 
manner (P < 0.01, Figure 1D). PHA-E-rhodamine co-localized 
to a subgroup of GFP-DAergic-N (Figure 1B). The fluorescence 
intensity of GFP-DAergic-N was decreased dose-dependently 
(P < 0.01, Figure 1E), suggesting a diminution of the GFP-DAT. 
The average size of GFP-DAergic-N was also reduced at the high-
est dose (P < 0.01, Figure 1F). PHA-E-rhodamine fluorescence 
image size was inversely proportional to the number, average 
intensity, and average size of the GFP-DAergic-N. The APS was 
increased dose-dependently (Figure 1G). The mean lifespan was 
increased at a medial dose (5.4 × 10−5 mM) from 17 to 23 days 
(39%, P < 0.05, Figure 1H).
Bandeiraea simplicifolia–TRITC (Sigma-Aldrich) co-localized 
with GFP-DAergic-N (Figure  2). The number of the GFP-
DAergic-N was reduced in a dose-dependent trend (P  >  0.05, 
Figure 2D). The fluorescence intensity of GFP-DAT protein in 
DAergic-N was dose-dependently reduced (P < 0.01, Figure 2E). 
The size of GFP-DAergic-N was elevated (P < 0.01, Figure 2F). 
The APS was dose-dependently decreased at all doses (Figure 2G). 
Mean lifespan was decreased at the highest dose (1.8 × 10−4 mM) 
from 17 to 10 days (−37%, P < 0.05, Figure 2H).
Griffonia Simplicifolia I (GSL-I)-rhodamine (Vector) did not 
show fluorescence co-localization, and did not affect the number 
or size of GFP-DAergic-N (Figures  3A,C). The fluorescence 
intensity of the neuron was increased at all doses (Figure 3B).
Dolichos biflorus agglutinin-rhodamine co-localized with 
GFP-DAergic-N within 3 days after feeding. In aged nematodes, 
50% of neurons co-localized with DBA-rhodamine at high doses 
(Figure  4). The number (Figure  4G), fluorescence intensity 
(Figure 4H), or size (Figure 4I) of DAergic-N were not altered 
(P > 0.05). In 2-day-old animals, the number of GFP-DAergic-N 
was similar to aged animals and 65–80% co-localized with 
DBA-rhodamine (Figures  4E,G). The size of GFP-DAergic-N 
was reduced in a dose-dependent trend at higher doses of 
DBA-rhodamine (P > 0.05) (data not shown). The fluorescence 
intensity and size of GFP-DAergic-N in 2-day-old animals were 
similar to aged animals (Figure 4E,F). The APS was increased at 
lower doses of DBA, and decreased at higher doses (Figure 4J). 
Mean lifespan was reduced at the highest dose (1.8 × 10−4 mM) 
from 19 to 11 days (−43%, P < 0.05, Figure 4K). Although some 
experiments were done adding lectin-specific inhibitory sugars to 
the medium for mitigation of the lectin effects, very high concen-
trations, up to 200 mM were needed to show any effects, and there 
were concerns about pleiotropic effects of these sugars fed at high 
amounts. For example, the animals died in presence of GalNAc 
(50 mM) within 2 days, possibly because of uridine diphosphate 
(UDP) depletion (68). Another example of problems with dosing 
live animals with dietary sugars to offset the lectin effects was that 
the mean lifespan was reduced by galactose (200 mM) from 19 to 
12 days (−36%, P < 0.05, Figure 5H). Use of high concentrations 
of sugars on whole animals had their own effects. Therefore, we 
have not included data herein using lectin-inhibitory sugars.
Arachis hypogaea agglutinin (PNA)-TRITC co-localized 
with GFP-GAergic neurons after 1-week treatment (1.8 × 10−5, 
5.4 × 10−5, 1.8 × 10−4 mM, Figure 5). The size and intensity of GFP-
GAergic neurons was not altered. The number of GFP-GAergic 
neurons was increased at low dose (1.8 × 10−5 mM, P < 0.05) and 
reduced at higher doses. APS was dose-dependently reduced at 
all doses (Figure 5G). Mean lifespan was reduced by higher doses 
(5.4 × 10−5 mM and 1.8 × 10−4 mM) from 19 to 15 and 14 days 
(−24 and −27%, P < 0.05, Figure 5H), with an increase at the 
highest dose (1.8 × 10−4 mM) from 12 to 16 days (33%, P < 0.05).
lectins altered the gFP-Daergic neurons 
Without co-localization
Lectins that alter number, GFP-intensity, or size of neurons 
without observed co-localization are given in Table 2.
Pisum sativum-rhodamine feeding did not reduce the num-
ber of GFP-DAergic-N (P  >  0.05, Figure  6A). However, the 
FigUre 1 | Phaseolus vulgaris (Pha-e)-rhodamine co-localized and diminished gFP-Daergic neurons in C. elegans post feeding. (a) GFP-DAergic 
neurons. (B) PHA-E-rhodamine in several GFP-DAergic neurons. (c) Merged (a,B) showing co-localization of the PHA-E-rhodamine with GFP-DAergic neurons. 
(D) Dose-dependent reduction of the number of GFP-DAergic neurons per animal: 4.4 ± 0.3 (2 × 10−3 mM, n = 3, P < 0.01). (e) Dose-dependent reduction of 
fluorescence intensity per GFP-DAergic neurons: 5,837 ± 556 (2 × 10−4–2 × 10−3mM, n = 3, P < 0.01). (F) Size reduction of GFP-DAergic neurons: 3.3 ± 0.4 μm2 
(2 × 10−3 mM, n = 3, P < 0.01). (g) The APS was increased dose-dependently. (h) Mean survival time of each group. *indicates statistical significance.
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fluorescence intensity (P < 0.001) and size (P > 0.05) of GFP-DAT 
in DAergic-N were dose-dependently decreased with PSA feed-
ing (P = 0.8, Figures 6B,C). In liquid culture, the number of the 
GFP-DAergic-N was not altered (Figure 6D), the intensity was 
diminished at high dose (4.3 × 10−4 mM, P < 0.05, Figure 6E), 
and the size was reduced at low dose (4.3 × 10−5 mM, P < 0.05, 
Figure  6F). The APS was increased at all doses (Figure  6G). 
Mean lifespan was increased by lower doses (4.3  ×  10−5  mM 
and 4.3 × 10−4 mM) from 22 to 27 days (22 and 23%, P < 0.05, 
Figure 6H).
Concanavalin A (Con A)-TRITC appeared to have a mild effect 
on the GFP-DAergic-N reducing the number of GFP-DAergic-N 
in a dose-dependent trend (Figure  7A). The fluorescence 
intensity of GFP-DAT protein image in DAergic-N was dose-
dependently increased by Con A feeding (P < 0.05, Figure 7B). 
The apparent size of GFP-DAergic-N was significantly reduced 
(P < 0.05, Figure 7C). Con A-TRITC did not alter the number 
of GFP-DAergic-N in liquid culture (P  >  0.05, Figure  7D), 
increased the intensity at high dose (1.9 × 10−4 mM, P < 0.05, 
Figure  7E), and decreased the size of neuron at middle dose 
(5.7 × 10−5 mM, P < 0.05, Figure 7F). The APS was increased 
at all doses (Figure 7G). Con A did not affect the mean lifespan 
(Figure 7H).
Triticum vulgaris (WGA)-rhodamine or WGA-TRITC was not 
detected as transported (Figure 8). The intensity of DAergic-N 
was increased (P < 0.05, Figure 8A), while the size of the neurons 
was decreased (P <  0.05) at the highest dose (4.6  ×  10−4  mM, 
Figure  8B). The APS was increased at all doses (Figure  8D). 
Mean lifespan was increased at the highest dose (4.6 × 10−4 mM) 
from 20 to 24 days (22%, P < 0.05, Figure 8E).
Triticum vulgaris (Succinylated) S-WGA-TRITC feeding had 
a similar effect as WGA-rhodamine. The number of DAergic-N 
did not show a significant change (Figure  9A), however, fluo-
rescent intensity of the GFP-DAergic-N was decreased (P < 0.05, 
FigUre 2 | Bandeiraea simplicifolia (Bs-i)-rhodamine co-localized with gFP-Daergic neurons: (a) gFP-Daergic neurons. (B) BS-I-rhodamine in 
GFP-DAergic neurons (5.26 × 10−4 or 1.75 × 10−3 mM). (c) Merged (a,B) showing co-localization of the BS-I-rhodamine with GFP-DAergic neurons. (D) Dose-
dependent reduction of GFP-DAergic neurons per animal: 7.0 ± 1.0 (1.75 × 10−4 mM) or 6.7 (1.75 × 10−3 mM) (n = 3, P > 0.05). (e) Reduction in fluorescence 
intensity per GFP-DAergic neuron (up to 60%): 4,468 ± 332 or 5,166 ± 300 (5.3 × 10−4 or 1.75 × 10−3mM, n = 3, P < 0.01). (F) The size of GFP-DAergic neurons 
was elevated dose-dependently from 8.0 ± 0.8 to 20.1 ± 1.7 μm2 (5.26 × 10−4) or 21.4 ± 2.5 μm2 (1.57 × 10−4) (n = 3, P < 0.01). (g) The APS was dose-
dependently decreased at all doses. (h) Mean survival time of each group. *indicates statistical significance.
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FigUre 3 | Griffonia simplicifolia i (gsl-i)-rhodamine appeared to affect the gFP-Daergic neurons. (a) GSL-I did not affect the number of the 
GFP DAergic neuron. (B) GSL-I increased fluorescence intensity of the neuron at all doses (P < 0.05). (c) GSL-I did not affect neuron size. *indicates 
statistical significance.
FigUre 4 | Dolichos biflorus agglutinin (DBa)-rhodamine in C. elegans co-localized with gFP-Daergic neurons of aged and young nematodes (l3). 
GFP-DAergic neurons in aged animals (a) or young animals (D). DBA-rhodamine in GFP-DAergic neurons in aged animals (1.0 × 10−3 or 3.33 × 10−3 mM) (B) or 
young animals (e). Merged (a,B) showing co-localization of the DBA-rhodamine with GFP-DAergic neurons in aged animals (c) or young animals (F). (g) The 
number of DAergic neurons was not altered (7.5, n = 5, P > 0.2) and 50% of them were co-localized with DBA-rb (1.0 × 10−3 or 3.33 × 10−3 mM, n = 3) in the aged 
animals. (h) The fluorescence intensity per GFP-DAergic neuron. (i) The size of the GFP-DAergic neurons was not changed. These observations were similarly seen 
in young animals. (J) The APS was increased at lower doses of DBA, and decreased at higher doses. (K) Mean survival time of each group. *indicates statistical 
significance.
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FigUre 5 | Arachis hypogaea agglutinin (Pna)-TriTc post-feeding C. elegans co-localized with gFP-Daergic neurons (leica, Tcs sP5, germany). 
(a) GFP-DAergic neurons (green), (B) PNA-TRITC in the neuron (red), (c) Co-localization of the GFP-DAergic neurons in merged (a,B) (yellow). (D) Number of 
GFP-DAergic neurons was increased at low dose (P < 0.05). (e) The intensity of GFP-DAergic neurons was not altered. (F) The size of GFP-DAergic neurons was 
not altered. (g) APS was dose-dependently reduced at all doses. (h) Mean survival time of each group. *indicates statistical significance.
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Figure 9B). The size of GFP-DAergic-N was slightly reduced in 
a dose-dependent trend (P = 0.4, Figure 9C). In these cases, it is 
not clear whether the lectin has some undefined indirect effect 
or that there is a direct effect by undetectable amounts of lectin. 
S-WGA-TRITC feeding C. elegans did not show co-localization in 
liquid culture. The number of the GFP-DAergic-N was decreased 
at lower doses (4.6  ×  10−5 mM and 1.4  ×  10−4  mM, P  <  0.05, 
Figure  9D). The fluorescent intensity of GFP-DAergic-N was 
increased at all doses (P  <  0.05, Figure  9E). The size of GFP-
DAergic-N was decreased at all doses (P < 0.05, Figure 9F). The 
APS was increased at a low dose, and decreased does-dependently 
at higher doses (Figure 9G). The mean lifespan was increased at a 
low dose (4.6 × 10−5 mM) from 21 to 23 days (9%, P < 0.05), and 
decreased at the highest dose (4.6 × 10−4 mM) to 12 days (−43%, 
P < 0.05, Figure 9H).
DiscUssiOn
Nine examined plant dietary lectins were conjugated to TRITC or 
rhodamine. Lectins were tested in the in vivo C. elegans (egIs1[Pdat-
1:GFP]) model. An elevated GFP-DAT that is expressed under 
control of the DAT gene promoter shows enhanced DAT expres-
sion and trafficking by the promoter, transcription factor, and 
nuclear receptor (69).
Carbohydrate-binding protein toxins are known to survive 
and traverse the gut intact, as an acutely toxic substance and can 
induce serious life-threatening illness in humans and animals. 
Distance pathogenicity of botulinum toxin, as well as cholera 
toxin, impairs the CNS (70). The present study was aimed at a 
new, surprising property of lectins based upon the hypothesis 
that lectins may be transported directly by gut absorption to local 
TaBle 2 | lectins alter number, gFP-intensity, or size of Daergic neurons without observed co-localization.
Fluorescence lectins Dose (mM) gFP # gFP intensity gFP size
Griffonia simplicifolia I (GSL-I)-rhodamine 5.2 × 10−4
↔ P > 0.05 ↑ P < 0.05 ↔ P > 0.051.7 × 10−3
5.2 × 10−3
Pisum sativum (PSA)-rhodamine (agar) 8.7 × 10−4 ↔ P > 0.05 ↓ P < 0.001 ↓ P > 0.05
8.7 × 10−3
Pisum sativum (PSA)-rhodamine (liquid) 4.3 × 10−5
↔ P > 0.05
↔ P > 0.05 ↓ P > 0.05
1.3 × 10−4 ↔ P > 0.05 ↔ P > 0.05
4.3 × 10−4 ↓ P > 0.05 ↔ P > 0.05
Concanavalin A (Con A)-TRITC (agar) 3.8 × 10−4
↔ P > 0.05
↔ P > 0.05
↓ P > 0.051.2 × 10−3 ↑ P < 0.05
3.8 × 10−3
Concanavalin A (Con A)-TRITC (liquid) 1.9 × 10−5
↔ P > 0.05
↔ P > 0.05 ↔ P > 0.05
5.7 × 10−5 ↔ P > 0.05 ↓ P > 0.05
1.9 × 10−4 ↑ P < 0.05 ↔ P > 0.05
Triticum vulgaris (WGA)-TRITC 4.6 × 10−5
↔ P > 0.05
↔ P > 0.05
↓ P < 0.051.4 × 10−4 ↔ P > 0.05
4.6 × 10−4 ↑ P < 0.05
Triticum vulgaris (Succinylated) S-WGA-TRITC (agar) 1.1 × 10−3
↔ P > 0.05 ↓ P < 0.05 ↔ P > 0.05
1.1 × 10−2
Triticum vulgaris (Succinylated) S-WGA-TRITC (liquid) 4.6 × 10−5 ↓ P < 0.05




↔ No significant alternation.
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neurons and transported axonally to distal neurons where they 
have an anatomical and potentially a physiological pathophysi-
ological effect. Fluorescent intensity and co-localization of lectins 
was observed to suggest transport to GFP-DAergic-N. Number 
and area changes of GFP-dopamine receptor fluorescence in 
DAergic-N were observed to be an effect of the lectins. For the 
fact that multiple system atrophy features the accumulation of 
α-SYN in glial cytoplasmic inclusions (71–73), involvement of 
other pathways such as indirect effects by interaction of lectins 
with glial cells that affected DAergic-N may be possible. Lectins 
have been used for histochemistry and neuronal tracing only, 
but were not previously associated with neuronal toxicity (26, 
74, 75).
The Occurrence and intensity of individual 
Fluorescently labeled lectins in gFP-
Daergic-n Detected by co-localization
Four lectins (PHA-E, BS-I, PNA, or DBA) appeared to co-localize 
with a subgroup of GFP-DAergic-N, while some other lectins had 
effects where co-localization was not observed. Because some 
effects were seen in neurons where lectins were not detected, 
this may be due to undetectable amount of transported lectin, 
or some unexplained indirect effect. Thus, the number and GFP-
DAT image of neurons were also evaluated, even when the fed 
lectin was not detected in the neurons. The lack of observation 
of fluorescence in the neurons using other fed lectins (which, 
however, seemed to affect these neurons) may be due to a variety 
of characteristics. For instance, a critical window for the lectin 
to be detectable may have been missed, the lectin may have been 
partially degraded, losing the fluorophore, but still retaining 
neuron-effective activity, or, more likely, undetectable levels of 
the lectin have observable activities. Future studies with ELISA, 
other immunocytochemical studies or radiolabeling may confirm 
the transport of small amounts of these specific lectins where an 
effect is observed without fluorescence co-localization.
lectin-caused Differences in the number 
of gFP-Daergic neurons
Four lectins [GSL-I (BSL I), PHA-E, Con A, and PSA] reduced 
the number of DAergic-N, with GSL-I having the greatest effect. 
Toxicity of some lectins and newly discovered side effects of 
ingestion of PHA and WGA lectins in human and animals have 
been observed, mitigated by sucrose feeding (76–78). In the 
present study, PHA-E-rhodamine appeared to be transported 
intracellularly, probably by axonal transport after ingestion, to C. 
elegans GFP-DAergic-N causing a reduction in their number. This 
reduction was inversely proportional to the size of the observed 
image of PHA-E-rhodamine fluorescence co-localized with the 
neurons. Thus, the greatest area of PHA-E-rhodamine co-stains 
with the lowest observed number of GFP-DAergic-N. In addi-
tion, both fluorescence intensity and size of the GFP-DAergic-N 
were significantly reduced, suggesting a possible toxic effect of 
cytoplasmic PHA-E. This observation is in agreement with other 
studies showing that PHA can damage intestinal epithelial cells 
(32, 78), which was prevented or reversed by a PHA-E inhibitor 
sucrose (78). Interestingly, PHA-E did not show a significant 
FigUre 6 | Pisum sativum (Psa)-rhodamine affected the gFP-Daergic neurons in C. elegans. (a) The number of GFP-DAergic neurons per animal was not 
reduced overall (8.70 × 10−4–8.7 × 10−3 mM, n = 6, P > 0.05). (B) The fluorescence intensity of GFP-DAergic neurons was decreased at high dose (651 ± 61, 
8.7 × 10−3 mM). (c) The size of GFP-DAergic neurons appeared to be reduced at high dose from 18.4 ± 0.9 μm2 (control) to 12.9 μm2 (8.70 × 10−4 mM, n = 3, 
P > 0.05) in a dose-dependent trend. Direct co-localization of PSA-rhodamine with GFP-DAergic neurons was not detected. (D) PSA alone did not affect the 
number of the neurons. (e) PSA decreased the intensity of DAergic neurons at the highest dose (P < 0.05). (F) PSA decreased the size of the DAergic 
neurons at lowest dose (P < 0.05), which was mitigated at the higher dose (P > 0.05). (g) The APS was increased at all doses. (h) Mean survival time of each 
group. *indicates statistical significance.
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decrease in the number and size of GFP-neurons in C. elegans but 
demonstrated decreased expression of GFP-DAT fluorescence 
intensity. PSA, in some studies, has been shown to be essentially 
non-toxic in mice both in vivo and in vitro (79). However, short-
term toxicity measurements in these studies do not include more 
subtle, possible long-term effects of neuronal damage.
lectin Feeding effects on the Fluorescent 
intensity of gFP-Daergic neurons
Three lectins (PHA-E, PSA, or S-WGA) reduced GFP-DAT fluo-
rescence in DAergic-N suggesting damage to DAT, while BS-I, 
GSL-I, or Con A induced an increase indicating a promotion of 
DAT in the DAergic-N. WGA slightly reduced the fluorescent 
intensity of GFP-DAT in DAergic-N, while DBA was inactive. 
Although WGA did not affect the number of GFP-DAergic-N 
in the present study, and in other laboratories, in the in vivo rat 
gut lumen, reduced expression of heat shock proteins resulting 
in lowered protection and greater permeability of epithelial cells. 
WGA also increases thrombin in human platelets, and escalates 
adipogenesis in mesenchymal cells of the mouse limb bud in vitro 
by unknown mechanisms (25, 77, 80, 81).
In liquid culture, individual lectins affect the number and 
intensity of GFP-DAergic-N in a different manner. GSL-I, Con A, 
WGA, and PSA mildly affected the number of GFP-DAergic-N. 
The intensity of GFP-DAergic-N was increased by GSL-I, Con 
A, and WGA, while decreased by PSA. The number of GFP-
DAergic-N was reduced, while the intensity of GFP-DAergic-N 
was increased by S-WGA in lower doses. PNA did not affect the 
intensity of the GFP-DAergic-N, while increased the number of 
neurons at lower doses.
FigUre 7 | Concanavalin A (con a)-TriTc in C. elegans appeared to have a mild effect on the gFP-Daergic neurons. (a) The number of GFP-DAergic 
neurons per animal was slightly reduced at the high dose (7 ± 0.4, P > 0.05). (B) The fluorescence intensity per GFP-DAergic neuron was dose-dependently 
increased from 691 ± 45 (control, n = 3) to 942 ± 118 (3.84 × 10−3 mM, n = 4, P < 0.05). (c) The size of GFP-DAergic neurons was significantly reduced from 
21.4 ± 1.8 μm2 (control) to 15.1 ± 0.7 μm2 (1.15 × 10−3 mM, n = 4, P < 0.05). Direct co-localization of Con A-TRITC with GFP-DAergic neurons was not detected. 
In liquid culture, Con A-TRITC in C. elegans appeared to have a mild effect on the GFP-DAergic neurons. (D) The number of the GFP-DAergic neuron was not 
affected (P > 0.05). (e) The fluorescent intensity of the DAergic neuron was increased at the highest dose (P < 0.05). (F) The area of GFP-DAergic neurons was 
decreased at middle dose (P < 0.05). (g) The APS was increased at all doses. (h) Mean survival time of each group. *indicates statistical significance.
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sizes of gFP-Daergic neurons
PHA-E or Con A significantly diminished the size of GFP-
DAergic-N, while BS-I, PSA, or S-WGA slightly reduced the size. 
Whether these effects signify damage to the neurons is not known. 
Increased neuron size of a subgroup of GFP-DAergic-N, however, 
was also observed with DBA or WGA, which may have promoted 
DAT expression, however, whether decrease or increase in the 
apparent size of neurons has a physiological effect, or indicates 
that lectin-mediated damage is not yet known.
The effect of lectins on the number of GFP-DAergic-N 
appeared in the following order PHA-E > GSL-I > BS-I > Con 
A > PSA > S-WGA. An elevation effect of lectins seemed to be in 
the order of DBA > BS-I > WGA > GSL-I, and ConA. It is now 
well known that O-linked β-N-acetylglucosamine (O-GlcNAc) 
is a common epitope on cytoplasmic and some nuclear proteins 
sharing common features with protein phosphorylation [see 
review (82)]. Although very difficult to detect due to sub-
stoichiometric amounts, O-GlcNAc occurs exclusively within the 
nuclear and cytoplasmic compartments of the cell and responds 
to external signaling, such as mitogen or antigen activation, by 
altering Ser- and Thr-phosphoprotein profiles (83–84). The pro-
tein modification is modulated by O-GlcNAcase and O-GlcNAc 
transferase, and even glucose levels modulate the O-GlcNAc 
cycling rate. Characteristics of half-life in O-GlcNAc cycling 
(≤1  min) have been linked closely to diabetes, cardiovascular 
disease, neurodegenerative disorders, and cancer. Many protein 
O-GlcNAc modifications occur in nucleocytoplasmic compart-
ments across plant and animal species, including humans [see 
review (82)]. WGA and other GlcNAc binding lectins, if present 
in the cytoplasm, may affect this balance (our hypothesis). PNA 
FigUre 8 | Triticum vulgaris (Wga)-rhodamine affected the intensity and area of Daergic neurons in liquid culture. (a) WGA did not affect the number 
of DAergic neurons (B) WGA increased the intensity of the GFP-DAergic neurons. (c) The area of the DAergic neurons was reduced at all doses (P < 0.05). (D) The 
APS was increased at all doses. (e) Mean survival time of each group. *indicates statistical significance.
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strengthens extracellular matrixes by promoting production of 
proteoglycan in mouse chondrocytes in  vitro (81). Similar to 
PNA, Con A has also been reported to strengthen extracellular 
matrixes in mouse chondrocytes in vitro (81). In our study, Con 
A altered GFP-DAergic-N by reducing the area of GFP-DAT 
fluorescence.
Some specific beneficial activities of a variety of lectins have 
been reported (81, 85). In our studies, DBA was observed in the 
GFP-DAergic-N that had the effect of increasing the observed 
area of the GFP-labeled DA transporter. This increase may sug-
gest enhanced DAT expression and trafficking, where GFP is 
expressed under the DAT promoter (69, 86). A major adverse 
effect of DBA lectin has not been reported elsewhere. In fact, DBA 
significantly facilitates cartilagenesis and osteogenesis in mouse 
limb bud mesenchymal cells in vitro (81).
BS-I and GSL-I displayed similar activities. Significantly, BSI 
I dose-dependently reduced the intensity of GFP-DAergic-N. 
Functionally, BS-I containing 5-Hydroxytryptophan (5-HTP), 
a catecholamine neurotransmitter, only binds to a subgroup of 
small dorsal root ganglion neurons, which are of the C-nociceptor 
type (C-fiber nociceptive or unresponsive) neurons. These 
C-nociceptor neurons mediate visceral pain and express recep-
tors to BS-I isolectin-B4 (IB4) (87–89). BS-I may increase 
thrombin in human platelets (80). One possible mechanism that 
might be related is over-excitation of neurons caused by exces-
sive glutamate neurotransmission being neurotoxic, which may 
cause neuronal death (90). Indeed, glutamatergic stimulation 
may indirectly induce DAergic neuronal death via unbalanced 
calcium homeostasis and oxidative stress, in vitro or in vivo (91). 
Some of these systems could be altered by either sugar-binding or 
other unexplored properties of lectins.
In liquid culture, PSA, Con A, WGA and S-WGA decreased 
the area of GFP-DAergic-N. GSL-I and PNA did not show sig-
nificant change.
elevated Fluorescent intensity and size 
of Daergic neurons
These alterations may reflect a relationship with the insulin 
receptor and DAT. Glucose provides a vital energy source for 
brain and clearly modulates neuronal function (92, 93). In C. 
elegans, hyperglycemia reduces APS, related to human diabetes. 
These relationships in our study, however, may represent some 
signaling interaction of glycemia/insulinemia and DAT. As with 
other catecholamine neurotransmitters, inhibitory neurotrans-
mitters are inversely proportional to glycemia, and DA kinetics is 
sensitive to hypoglycemia in a complex manner (94). In rodents, 
insulin receptors and DAT are densely present in substantia nigra, 
insulin may increase DAT mRNA expression, and glycemic index 
is inversely associated with the risk of PD (95, 96).
lectins affect average Probability of 
survival of C. elegans
Lectins can be categorized into three groups based on their effects 
on APS of C. elegans. (1) PHA-E, DBA, and S-WGA showed 
J-shaped effects on APS that was increased with lower doses, 
while decreased at higher doses. (2) PSA, Con A, and WGA 
demonstrated augmented effects on APS that was increased at all 
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FigUre 9 | Triticum vulgaris (succinylated) s-Wga-TriTc affected C. elegans gFP-Daergic neurons. (a) The number of GFP-DAergic neurons per animal 
was similar to the effect of WGA-TRITC (7.3–7.0, n = 4, P > 0.5). (B) The fluorescence intensity was reduced from 735 ± 26 (control) to 667 ± 25 (1.11 × 10−2 and 
11.12 × 10−3, n = 4, P < 0.05). (c) The size of GFP-DAergic neurons were slightly reduced at the high dose only to 9.2 ± 0.6 μm2 (11.12 × 10−2, n = 4, P = 0.4). 
Direct co-localization of WGA-TRITC with GFP-DAergic neurons was not detected. S-WGA-TRITC affected the GFP-DAergic neurons in liquid culture. (D) The 
number of the GFP-DAergic neurons was decrease at low doses. (e) The fluorescence intensity of the GFP-DAergic neurons was increased. (F) The size of the 
GFP-DAergic neurons was decreased. (g) The APS was increased at a low dose, and decreased does-dependently at higher doses. (h) Mean survival time of each 
group. * indicates statistical significance.
doses in a dose-dependent manner. (3) GSL-I and PNA decreased 
the APS dose-dependently.
Neurotoxins such as botulinum toxin or ricin bind to specific 
receptors on cell membrane, to be internalized, and exert toxic 
effects (97, 98). Similarly, lectins bind to carbohydrate ligands 
of targeted cells to be functional, producing effects. Specific 
sugars may competitively bind and inhibit lectins uptake (99). 
Structurally similar lectins might share similar binding recep-
tors and compete for each other’s binding sites. The complex 
GI environment, including nutrients and cellular environment, 
might alter the absorption of certain lectins and their potential 
biological consequences (100).
In a recent Danish report, patients who had vagal nerves 
removed 20  years earlier had 40% lower incidence of PD than 
control populations. If dietary proteins are one potential etiology 
for PD, by transport to neurons from the gut, as hypothesized 
here, removal of the vagal nerve would have prevented or reduced 
this etiology pathway. Symptoms of motor impairment are typi-
cal in PD patients, and dysfunction of aspects of the autonomic 
nervous system are often underrated, such as GI motility (101), 
rapid eye movement (102), and so on. The current study indicates 
potential transport of some dietary plant lectins from the GI tract 
to the DAergic-N in C. elegans, with direct or indirect effects on 
these neurons and diverse effects on APS. This observation may 
be related to the Braak and Hawkes’ hypothesized unknown etio-
logic agent for PD or related, for example, to damaged DAergic-N 
that have been found in PD (40, 47). If related, the process may be 
gradual, may be additive, related to the frequency of consumption 
of certain lectins, and may be determined by the association of 
lectins with other factors. Certainly, there is potential for inputs 
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